Loading...
Loading...
Also known as: Growth Hormone Releasing Peptide-2
Synthetic ghrelin mimetic that stimulates GH release with moderate appetite stimulation.
Benefits
6
Conditions
5
Evidence
Clinical trials, preclinical research+ studies
Source
Synthetic hexapeptide ghrelin mimetic
Gabriel Brain Score
Moderate
Synthetic ghrelin mimetic that stimulates GH release with moderate appetite stimulation.
Binds ghrelin receptor (GHS-R1a) to trigger GH release, moderate cortisol and prolactin elevation, increases appetite via ghrelin pathway, synergistic with GHRH analogs for maximal GH pulse.
* Dosing should be individualized. Always consult with a qualified healthcare practitioner.
Clinical trials, preclinical research
Clinical evidence for GH stimulation. Less selective than ipamorelin (affects cortisol/prolactin). Effective for GH elevation when combined with GHRH analogs.
Synthetic GHRH analog FDA-approved for reducing visceral adipose tissue in HIV-associated lipodystrophy.
Potent hexapeptide ghrelin mimetic with strong GH-releasing effects and cardioprotective properties.
Long-acting GHRH analog that stimulates sustained growth hormone release.